FAST‐CRISPR: Fusogenic Association and Secured Transfection of CRISPR/Cas9 Ribonucleoproteins Using Lipid‐Silica Hybrid Nanoparticles for Therapeutic Genome Editing
Small · 2026
DOI: 10.1002/smll.202511362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2026. Verfasst von Minjong Kim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Science, Ulsan National Institute of Science and Technology, Ulsan, Republic of Korea. Hauptthemen laut MEDLINE: Silicon Dioxide, Nanoparticles, Ribonucleoproteins, Lipids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korean ARPA-H Project through the KHIDI, Korean Fund for Regenerative Medicine (KFRM), National Research Foundation (NRF).
Abstract (Originalsprache)
Clinical translation of CRISPR/Cas9 therapeutics is challenged by inefficient cytosolic delivery and toxicity issues associated with viral vectors and nanoparticle‐based carriers. To overcome these concerns, herein we report a lipid‐silica hybrid nanoparticle platform for fusogenic association and secured transfection of CRISPR/Cas9 (FAST‐CRISPR), designed for rapid cytosolic delivery of CRISPR/Cas9 ribonucleoproteins, followed by efficient gene editing. Through direct fusion with the plasma membrane and bypassing conventional endocytic barriers, FAST‐CRISPR nanoparticles displayed superior intracellular delivery efficacy. Optimizing lipid compositions, we discovered that a 1:1 weight mixture of cationic DOTAP and ionizable DODMA lipids, combined with tailored large‐pore silica nanoparticles, enables enhanced loading capacity, rapid cytosolic dispersion, and significant nuclear transport of Cas9/gRNA complexes. FAST‐CRISPR nanoparticles efficiently delivered multiplex genome‐targeting ribonucleoproteins to induce targeted double‐strand DNA breaks, triggering apoptosis in cancer cells and significantly suppressing tumor growth in a mouse xenograft model without systemic toxicity. Our findings demonstrate the therapeutic efficacy and translational potential of FAST‐CRISPR nanoparticles as a safe and versatile non‐viral delivery platform for precision genome editing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Science, Ulsan National Institute of Science and Technology, Ulsan, Republic of Korea.
- Center for Genomic Integrity, Institute of Basic Science, Ulsan, Republic of Korea.
- Department of Chemistry, Ulsan National Institute of Science and Technology, Ulsan, Republic of Korea.
- Department of Biomedical Engineering, Ulsan National Institute of Science and Technology, Ulsan, Republic of Korea.
- In Vivo Research Center, UNIST Central Research Facilities, Ulsan National Institute of Science and Technology, Ulsan, Republic of Korea.
- Division of Research and Development, CasCure Therapeutics, Seoul, Republic of Korea.
ORCID-Profile: Jinmyoung Joo
Förderung
- Korean ARPA-H Project through the KHIDI
- Korean Fund for Regenerative Medicine (KFRM)
- National Research Foundation (NRF)
- Institute for Basic Science
- UNIST research fund
- Korea Basic Science Institute
- Ulsan National Institute of Science and Technology
Zitieren
APA
Kim, M., Kim, K., Lee, J., Lee, S., Choi, S., Park, S. A., Jeong, E., Choi, S. Y., Park, H. H., Park, T. E., Kwon, T., Myung, K., Yoo, J., Cho, S. W., & Joo, J. (2026). FAST‐CRISPR: Fusogenic Association and Secured Transfection of CRISPR/Cas9 Ribonucleoproteins Using Lipid‐Silica Hybrid Nanoparticles for Therapeutic Genome Editing. Small. https://doi.org/10.1002/smll.202511362
Vancouver
Kim M, Kim K, Lee J, Lee S, Choi S, Park SA, et al. FAST‐CRISPR: Fusogenic Association and Secured Transfection of CRISPR/Cas9 Ribonucleoproteins Using Lipid‐Silica Hybrid Nanoparticles for Therapeutic Genome Editing. Small. 2026. doi:10.1002/smll.202511362
BibTeX
@article{Kim2026,
author = {Kim, Minjong and Kim, Kyunghwan and Lee, Jihyun and Lee, Soyoung and Choi, Subin and Park, Soo Ah and Jeong, Euihwan and Choi, Song-Yi and Park, Hee Ho and Park, Tae-Eun and Kwon, Taejoon and Myung, Kyungjae and Yoo, Jounghyun and Cho, Seung Woo and Joo, Jinmyoung},
title = {FAST‐CRISPR: Fusogenic Association and Secured Transfection of CRISPR/Cas9 Ribonucleoproteins Using Lipid‐Silica Hybrid Nanoparticles for Therapeutic Genome Editing},
journal = {Small},
year = {2026},
doi = {10.1002/smll.202511362}
}
EUVIMED